Thynk Capital — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Theragenepharmatheragenepharma.comJul 2015
Theragene Pharmaceuticals develops immunotherapy and gene therapy treatments for cancer and cardiovascular diseases using AAV technology.
BiotechDigital HealthMedical DevicesSan Diego, US
Jon Berglin(Executive Officer, Director)
BoardSteven Davis(Director)Daniel Coury(Director)Chaojie Zhang(Director)
PartnerJim Plante· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.